logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Investing as Shakespearean Tragedy: The Story of Ariad Pharmaceutical (ARIA)

By  +Follow November 12, 2013 8:57AM
Share:
Tickers Mentioned:

Shares in Ariad Pharmaceuticals (ARIA) were up 10.78 percent on Veterans Day. Even for a small-cap like Ariad, coming in at a valuation just under a half billion dollars, that’s normally what one would consider a pretty solid bounce. That’s a day that, for a lot of investors, would stand out. However, for the battered shareholders of Ariad, it probably doesn’t even register any more. Okay, that’s not true, double-digit jumps always register. But after the Odyssey Ariad’s been on for the last month, it’s not difficult to imagine that days like Monday just get lost in the shuffle.

It’s not often you see a company go on a ride like Ariad just has, plunging sharply, appearing to rally, rinse and repeat. And it’s a drama that’s swept a lot of people up. Over the last 3 months, Ariad’s moved an average of 11.14 million shares a day, good to make it the 75th most traded security over that period, one spot behind Elon Musk’s Tesla Motors (TSLA) , a battleground stock and the source of general market fascination. That’s a class that contains mostly mega-cap blue chips and high-profile ETFS, relatively few small-cap companies. And that’s not even the whole story. Ariad’s heavy volume is drawn mostly from the massive spike this last month. Over the last 30 days Aria has been moving an average of 20 million shares a day, meaning that more than 10 percent of outstanding shares are trading hands on an average day.

So what’s happening with this company? The story’s a simple one, but, for Ariad investors, it’s a tragic one.

Volatile Month

Lets start with the whole story: since the start of October, Ariad Pharmaceutical’s stock has lost over 85 percent of its value. No matter how specifically you pull things apart, that’s the simple fact one cannot avoid. Especially if you’ve owned Ariad for that whole stretch. But inside that one big sell-off is a series of daily price moves that could drive an investor insane. Here’s a timeline or the events that have brought Ariad so much grief:

October 8:

After market close, news gets out regarding the clinical trials for Ariad’s leukemia drug Iclusig and it’s bad. In fact, if you’re long Ariad, it’s positively awful. The drug showed blood clots developing in 11.8 percent of people treated with Iclusig after 24 months. This was a big jump from the 8 percent rate found after 11 months, and it prompts the FDA to block Ariad from enrolling any new patients to drug trials for Iclusig.

Like most small-cap pharma companies, Ariad’s future is tied mainly to just a couple of drugs, and the news that one of them might not be safe is pretty drastic. Especially when one considers that the nearly 800 percent gains from the start of 2010 to October 7 had a lot to do with the fact that Iclusig looked so promising, even getting accelerated approval based on its Phase 2 clinical data.

So it shouldn’t be surprising that the market’s reaction was swift and vengeful. As soon as investors got a crack at selling their position on October 9 shares plummeted over 65 percent.

October 10-18:

If the story ended there, it would be pretty much in line with a familiar narrative: small-cap pharma plummets on negative results of clinical trial. But, while nothing matched the degree of the move on the ninth, Ariad kept trading at heavy volumes and kept posting double-digit moves.

A series of analyst downgrades hit the company on October 10, with Barclays (BCS) downgrading the stock from overweight to underweight and cutting the price target from $25 a share to $4 (ouch). The stock kept falling, losing another 30 percent from October 10-16 but coasting into what appeared to be a bottom on October 16.

Then, on October 17, signs of life! Following comments from JP Morgan (JPM) analyst Cory Kasimov that physicians may not be all that concerned about the blood clots, the stock rebounded, posting a 10.78 percent gain and potentially giving hope to Ariad owners that the worst was behind them.

Except that it wasn’t. Not at all. October 18, word came out that Ariad and the FDA had agreed to halt testing of Iclusig entirely based on the rate of blood clotting incidences. The discontinuation of the late-stage trial dubbed Epic by Ariad caused shares to plunge more than 40 percent that day.

October 21-October 30:

After any stock gets hammered that hard in that short a period, one might expect it to bounce back. At least a little. Considering how steep the discount it’s trading at as compared to a mere two weeks ago, it has to garner at least a little interest, right?

And it did. The company staged a pretty substantial rally, gaining almost 50 percent in just nine days. It’s not much when one considers just how fall the stock fell prior to the rally, but at least the battered shareholders got a respite in the end, right?

October 31:

Only it wasn’t the end. Halloween was extra spooky if you had decided to wait out Ariad’s steep decline. Ariad announced that it would suspend marketing and distribution of Iclusig while it "continues to negotiate updates to the U.S. prescribing information." In retrospect, it certainly seems as though this shouldn’t have been all that surprised, but it clearly surprised at least some people as the company’s stock plunged nearly 45 percent.

And Beyond…?

Where Ariad’s going from here is unclear. Since the start of November, the stock’s up over 15 percent, including a 17.27 percent leap the day after Halloween and Monday’s double-digit gain. However, precisely what to expect moving forward is unclear. In the event that Ariad can return Iclusig to the market and ensure that it’s safe, there’s a pretty good chance the stock takes off. That said, there’s no real way to know whether or not that’s possible. In the meantime, the company announced that it was shedding 40 percent of its American-based workforce on November 7.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for ARIA
Stock Rocket
28 Nov 14 17:58:13
Thanks to the 5 pro traders at http://t.co/5jbX6mNKQv for an amazing week! My win rate was 80%. So sweet. $ARIA $GNBT $CIG $NVAX
chartguy89
28 Nov 14 17:09:47
ARIA -2.47% Stock Charts $ARIA Ariad Pharmaceuticals Inc. (NASDAQ) Last Updated: 11/28/2014 19:09:52 ARIA Stoc http://t.co/YdHulivCUI
seb1a
28 Nov 14 16:31:56
RT @InvestorsLive: That was a FREE video by the way .... http://t.co/8sulgM2M16 $GPRO $ARIA $BITA $OAS $ARCP $CJES $BCEI Enjoy
Trader News Daily
28 Nov 14 15:53:09
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $BSBR $ARIA $GALE $NBG $MHR
PennyStock Zone
28 Nov 14 15:49:41
'Choose yourself!' book review http://t.co/eI9c5QLAlt $AMOT $ARIA $BDR $CAMT $CDZI $DGLY $FSI $INTT $MNDO $NVEE
Stock Rocket
28 Nov 14 15:14:56
Thanks to the 5 pro traders at http://t.co/5jbX6mNKQv for an amazing week! My win rate was 80%. So sweet. $ARIA $GNBT $CIG $NVAX
Nathan Michaud
28 Nov 14 14:53:10
That was a FREE video by the way .... http://t.co/8sulgM2M16 $GPRO $ARIA $BITA $OAS $ARCP $CJES $BCEI Enjoy
Profit.ly
28 Nov 14 14:11:55
RT @InvestorsLive: http://t.co/8sulgM2M16 - Posted a New Video Lesson: #959-961 FREE $GPRO $ARIA $BITA $OAS $VGGL Great Trading Today!
PennyStock Zone
28 Nov 14 13:53:39
5 Totally Random Ideas: http://t.co/eI9c5QLAlt $AMOT $ARIA $BDR $CAMT $CDZI $DGLY $FSI $INTT $MNDO $NVEE
Brooklyn Trader
28 Nov 14 13:12:55
Swing Trading Week in Review http://t.co/hGkQMzKHRr $CNIT $ARIA $SD $RLOC $MEIP Have a nice w/e
Nathan Michaud
28 Nov 14 12:45:02
http://t.co/8sulgM2M16 - Posted a New Video Lesson: #959-961 FREE $GPRO $ARIA $BITA $OAS $VGGL Great Trading Today!
Dan Forman
28 Nov 14 12:29:57
Current portfolio: $aria $fb $scty $rig $wmb $celg $bac $jpm $cvs $fkinx $fslr $nvda $hcp $nyny $rpm $T $latf $mcig
SmallCaps
28 Nov 14 11:36:14
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszr3DgF $AMOT $ARIA $BDR $CAMT $CDZI $DGLY $FSI $INTT $MNDO $NVEE
Stephen s
28 Nov 14 11:31:30
RT @StockerPenny: $ELED is breaking out of bullish flag pattern today. Could be a big couple days here. Enjoy! $ARIA $MYEC $SWET
Stephen s
28 Nov 14 11:31:27
RT @MarkyMarkTrades: Thanks to the pros at http://t.co/6cvEHBeuNR for the $TINO swing trade idea. Up 45% so far. $ARIA $MYEC $SWET
Dan Forman
28 Nov 14 10:47:50
RT @dougheuringaria: Jmp Weekly prescription data for Imbruvica $PCYC $ARIA $CELG were released by Symphony Health Solutions and IMS http:/…
Mark Trader
28 Nov 14 10:38:16
Thanks to the pros at http://t.co/6cvEHBeuNR for the $TINO swing trade idea. Up 45% so far. $ARIA $MYEC $SWET
PennyStocker
28 Nov 14 10:32:55
$ELED is breaking out of bullish flag pattern today. Could be a big couple days here. Enjoy! $ARIA $MYEC $SWET
Lucretia
28 Nov 14 10:31:25
$ARIA Insider Trading Alerts for Hertz, Ariad Pharmaceuticals, J C Penney, Sirius XM ... http://t.co/rMHVH4etSk
Stephen s
28 Nov 14 10:23:28
RT @BoilerWarrior: http://t.co/iQWRYqnOQl....Top penny stocks, NYSE, and NASDAQ trades from the stock market today. +296% last week. $ARIA…
Wall Street
28 Nov 14 10:17:40
http://t.co/iQWRYqnOQl....Top penny stocks, NYSE, and NASDAQ trades from the stock market today. +296% last week. $ARIA $MYEC $SWET
Dave
28 Nov 14 10:05:01
I didnt know the pro members get the opening bell alerts from http://t.co/qY5MPlJPrU 1 day early. $ARIA $HK $GERN $NIHDQ $AU $SIMH
iHangout
28 Nov 14 10:04:15
lookn4wins: ALERTS, HOT STOCKS & CHARTS: ARIA -1.92% Stock Charts $ARIA Ariad http://t.co/qGMWMlE6K2
lookn4wins
28 Nov 14 10:01:16
ARIA -1.92% Stock Charts $ARIA Ariad Pharmaceuticals Inc. (NASDAQ) Any opinions on ARIA? Please reply to this http://t.co/n2nMEp9XKL
biotech 2050
28 Nov 14 09:55:10
RT @dougheuringaria: Jmp Weekly prescription data for Imbruvica $PCYC $ARIA $CELG were released by Symphony Health Solutions and IMS http:/…
StockAviator.com
28 Nov 14 09:46:32
Join thousands of traders at http://t.co/30Wzoc9t1Q. 5 pro trading gurus alerted 500% gains last week. $GSAT $BBRY $ZNGA $RAD $ARIA
dougheuring
28 Nov 14 09:43:34
Jmp Weekly prescription data for Imbruvica $PCYC $ARIA $CELG were released by Symphony Health Solutions and IMS http://t.co/V3ZRXmkPmM
Stockaholics
28 Nov 14 09:42:46
Our Penny Stock Pick On $STTK Is Up 128.57% In 2 Days! Major Update: http://t.co/oR27rFfh2v $FASC $ARIA $TUCN
Victor Roberts, MD
28 Nov 14 09:24:33
Commented on StockTwits: Yes, exactly right. But I won't be writing 7$ puts, 6$ is safer. $ARIA is too vulnerable... http://t.co/AqTneYrucg
The Cardiac Kid
28 Nov 14 09:10:52
[SMART MONEY] : $ARIA OVER 25% ABOUT 45M SHORTS = http://t.co/9HEP8TUqFh: [SMART MONEY] http://t.co/Qan8wJkFAS
PennyStockSuperstar
28 Nov 14 09:05:07
Check out our alert track record here... http://t.co/BdiZMRYWH1. Sign up is free. See you soon! $PDLI $NBG $FTR $ARIA $CNET $COT
Jack Trader
28 Nov 14 09:02:56
$ARIA Ariad Pharmaceuticals, Inc. - Product Pipeline Review - 2014 http://t.co/hMbwVSO7hZ
Victor Roberts, MD
28 Nov 14 09:00:00
Commented on StockTwits: $ARIA HFT/Algo just took out stop losses of long day traders! Look at green vol bar afte... http://t.co/PvU0GLLTba
danrocks
28 Nov 14 08:54:55
Right now ARIA is number 83 for the largest percentage gain out of 250 stocks. $ARIA ARIA is up +11.87% in the http://t.co/XAY7pAdltj
danrocks
28 Nov 14 08:54:31
$ARIA ARIA Stock is number 83 for the largest percentage gain out of 250 stocks. $ARIA ARIA is up +11.87% in the las http://t.co/f9DVxCq6Ys
Trent Blair
28 Nov 14 08:37:52
RT @Drragu: $ARIA I May be too optimistic, but if momentum continues $ARIA can gap fill & recover last yr levels @ 20 by EOY? GL http://t.c…
Keyser Söze
28 Nov 14 08:37:21
I have enjoyed the investment and positive stream of news behind $ARIA http://t.co/umR61WiRfC
Joshua Payne
28 Nov 14 08:17:41
RT @InvestorsLive: What I am thankful for -- read it !! Took some time !! http://t.co/7EiF8mplM9 $GPRO $ARIA $EJ $BITA $CERS $HAL $VGGL $XO…
Nathan Michaud
28 Nov 14 08:16:29
What I am thankful for -- read it !! Took some time !! http://t.co/7EiF8mplM9 $GPRO $ARIA $EJ $BITA $CERS $HAL $VGGL $XOMA
Victor Roberts, MD
28 Nov 14 08:15:06
Commented on StockTwits: i started accumulatung $ARIA swing trade positon @ 5.50 after triple bottom recovery, ev... http://t.co/LfeUdAXW1s
Matt Huckelbery
28 Nov 14 08:11:22
Vargatef cleared in Europe for lung cancer http://t.co/ZIy2tvU5UO $ARIA I am long $ARIA from $7.17 a couple of days ago. Chart play for me.
Trent Blair
28 Nov 14 08:10:06
$ARIA still slowly grinding up.
Victor Roberts, MD
28 Nov 14 07:41:14
Commented on StockTwits: Big mistake, u r capping your $ARIA gains. Add 8$ calls and sell 7$ Puts. did u see @sur... http://t.co/LvF6hi0GOF
Victor Roberts, MD
28 Nov 14 07:34:50
Commented on StockTwits: GL. If u r this happy, how would you react if $ARIA is above 8 & all the way to 10s? Dyi... http://t.co/aoFwpoo6wI
Trader News Daily
28 Nov 14 07:33:39
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $BSBR $ARIA $GALE $NBG $MHR
PennyStocker
28 Nov 14 07:33:35
Wowser $ELED in breakout mode. Going long on the 8k news. $ARIA $MYEC $SWET
The Cardiac Kid
28 Nov 14 06:52:46
crudeoil24: $ARIA > Huge info!: crudeoil24 http://t.co/qDCCsRO2XK
The Cardiac Kid
28 Nov 14 06:52:46
[SMART MONEY] : $ARIA 7.43 CLEARED FOR LUNG CANCER IN EUROPE http://t.co/IRyqylcYMx: [SMART MONEY] http://t.co/SdhlRFH4Fs
T Abuhasna
28 Nov 14 06:52:20
Vargatef cleared in Europe for lung cancer $IBB $BIB $IRY $BIS $IXJ $DRGS $BMY $MRK $CLVS $FPRX $BIND $ARIA http://t.co/PYNznek3cP
StockBoardAsset
28 Nov 14 06:48:53
$ARIA 1box Rev multi top breakout w/ upthrust http://t.co/b5iAqQYn9D
				
				
By  +Follow November 12, 2013 8:57AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.